Center for Crohn's Disease & Ulcerative Colitis
Inflammatory bowel disease (IBD) requires consistent long-term evaluation and management. At the Center for Crohn’s Disease & Ulcerative Colitis, Board Certified gastroenterologists provide personalized, ongoing care for patients suffering from all types of IBD, most commonly Crohn’s Disease and ulcerative colitis.
While Crohn’s and colitis are chronic and there is no cure, the Center offers individualized treatment plans that help alleviate symptoms and promote remission of the disease. Our goal is to medically suppress a patient’s inflammatory response and allow the intestinal tissue to heal. Once remission is induced and symptoms like fever, diarrhea and abdominal pain are brought under control, we then turn to therapies that will maintain remission and decrease the frequency of symptomatic flare-ups.
In addition to providing the most up-to-date treatment options such as anti-inflammatory agents, corticosteroids, immunomodulators, and biologic therapies, the Center’s medical staff participates in FDA-approved clinical trials to investigate new drugs and methods of treatment. Currently, the Center for Crohn’s Disease & Ulcerative Colitis is conducting multiple research trials that are open to patients with varying degrees of IBD. For more information about these trials and to see if you are eligible to participate, please call the number below. By offering the opportunity to try investigational drugs, patients not only increase their chances of gaining a better quality of life, but they also make an important contribution to national research efforts in treating both Crohn’s disease and ulcerative colitis.
To Schedule Appointments and for Information About Current Clinical Trials:
Emory Saint Joseph’s Office
5671 Peachtree-Dunwoody Road, Suite 600
Atlanta, GA 30342
Douglas Wolf, M.D., Medical Director